PSNPrescribable
fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Wixela Inhub Powder
RxNorm Crosswalk NDC 0378-9321
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Wixela Inhub (NDC 0378-9321) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 6 unique RxNorm concepts. By anchoring Mylan Pharmaceuticals Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
(RxCUI 896184)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
(RxCUI 896209)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
(RxCUI 896228)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Wixela Inhub 100/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
(RxCUI 2110510)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
(RxCUI 2110513)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Wixela Inhub 500/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
(RxCUI 2110516)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Wixela Inhub
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 0378-9321 to RxCUI 2110510, 2110513, 2110516, 896184, 896209, 896228, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
* Please review the full disclaimer at the bottom of this page.
